Sex-differential Host-microbiome CVD Risk - A Longitudinal Cohort Approach — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Sex-differential Host-microbiome CVD Risk - A Longitudinal Cohort Approach — Stella

Home/Transgender/

View on ClinicalTrials.gov

Recruiting

Back to Transgender trials

Trial locations(1 site)

Germany

Experimental and Clinical Research Center, Clinical Research Unit, Berlin

Key details

Sponsor

Charite University, Berlin, Germany

Collaborators

Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK)

Enrollment target

~200 participants

Started

August 2022

Primary completion

December 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years – 50 Years

Last updated February 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.